4192023
Targeting a hidden conformation to design safer psychedelic therapies
Date
March 23, 2025
Related Products
Drug Design: Intractable Diseases and Drug Development
: [COMP] Division of Computers in Chemistry
Computational design of selective agonists for the serotonin 2A receptor
Mental health and substance use disorders represent the leading cause of years lost to disability or premature death in the United States…
Computational design of selective agonists for the serotonin 2A receptor | Poster Board #3218
Mental health and substance use disorders are the leading cause of disease burden in the United States. Psychedelic drugs—such as LSD and “magic mushrooms”, which act as agonists at the serotonin 2A receptor (5-HT2AR)—are proving effective in treating these disorders…
Computational design of selective agonists for the serotonin 2A receptor
Mental health and substance use disorders represent the leading cause of years lost to disability or premature death in the United States…